Atopic Dermatitis -Epidemiology Forecast to 2027

Atopic Dermatitis -Epidemiology Forecast to 2027

Category

Pharmaceuticals

Published Date

1st Feb 2018

Pages

50

Choose License

Final Price

DelveInsight's "Atopic Dermatitis (AD) - Epidemiology Forecast, 2027” report provides a comprehensive analysis of the Atopic Dermatitis (AD) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2027.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2027

Atopic Dermatitis (AD) Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Atopic Dermatitis (AD) in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Atopic Dermatitis (AD) outlook. It also includes the explanation of changing trends of epidemiology outlining the Atopic Dermatitis (AD) scenario.

Atopic Dermatitis (AD) Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Atopic Dermatitis (AD) thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Atopic Dermatitis (AD) explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Atopic Dermatitis (AD) Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Atopic Dermatitis (AD)

Key assessments
• Patient Segmentation in Atopic Dermatitis (AD)
• Atopic Dermatitis (AD) Risk & Burden
• Factors driving growth in a specific Atopic Dermatitis (AD) patient population
1. Report Introduction
2. Atopic Dermatitis (AD) Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Atopic Dermatitis (AD) in 2017
2.2. Patient Share Distribution of Atopic Dermatitis (AD) in 2027
3. Disease Background and Overview: Atopic Dermatitis (AD)
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Atopic Dermatitis (AD) in 7MM
4.3. Total Prevalent/ Incident Patient Population of Atopic Dermatitis (AD) in 7MM – By Countries
5. Epidemiology of Atopic Dermatitis (AD) by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Atopic Dermatitis (AD)
5.1.3. Sub-Type Specific cases of the Atopic Dermatitis (AD) *
5.1.4. Sex- Specific Cases of the Atopic Dermatitis (AD)*
5.1.5. Diagnosed Cases of the Atopic Dermatitis (AD)
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Atopic Dermatitis (AD)
5.4.3. Sub-Type Specific cases of the Atopic Dermatitis (AD)*
5.4.4. Sex- Specific Cases of the Atopic Dermatitis (AD)*
5.4.5. Diagnosed Cases of the Atopic Dermatitis (AD)
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Atopic Dermatitis (AD)
5.5.3. Sub-Type Specific cases of the Atopic Dermatitis (AD)*
5.5.4. Sex- Specific Cases of the Atopic Dermatitis (AD)*
5.5.5. Diagnosed Cases of the Atopic Dermatitis (AD)
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Atopic Dermatitis (AD)
5.6.3. Sub-Type Specific cases of the Atopic Dermatitis (AD)*
5.6.4. Sex- Specific Cases of the Atopic Dermatitis (AD)*
5.6.5. Diagnosed Cases of the Atopic Dermatitis (AD)
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Atopic Dermatitis (AD)
5.7.3. Sub-Type Specific cases of the Atopic Dermatitis (AD)*
5.7.4. Sex- Specific Cases of the Atopic Dermatitis (AD)*
5.7.5. Diagnosed Cases of the Atopic Dermatitis (AD)
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Atopic Dermatitis (AD)
5.8.3. Sub-Type Specific cases of the Atopic Dermatitis (AD)*
5.8.4. Sex- Specific Cases of the Atopic Dermatitis (AD)*
5.8.5. Diagnosed Cases of the Atopic Dermatitis (AD)
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Atopic Dermatitis (AD)
5.9.3. Sub-Type Specific cases of the Atopic Dermatitis (AD)*
5.9.4. Sex- Specific Cases of the Atopic Dermatitis (AD)*
5.9.5. Diagnosed Cases of the Atopic Dermatitis (AD)
6. Unmet Needs of the Atopic Dermatitis (AD)
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific
Table 1: Total Prevalent/Incident Cases of the Atopic Dermatitis (AD) in 7MM
Table 2: Total Prevalent/Incident Cases of the Atopic Dermatitis (AD) in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Atopic Dermatitis (AD) in United States (2016-2027)
Table 4: Sub-Type Specific cases of the Atopic Dermatitis (AD) in United States (2016-2027)*
Table 5: Sex- Specific Cases of the Atopic Dermatitis (AD) in United States (2016-2027)*
Table 6: Diagnosed Cases of the Atopic Dermatitis (AD) in United States (2016-2027)
Table 7: Prevalent/Incident Cases of the Atopic Dermatitis (AD) in Germany (2016-2027)
Table 8: Sub-Type Specific cases of the Atopic Dermatitis (AD) in Germany (2016-2027) *
Table 9: Sex- Specific Cases of the Atopic Dermatitis (AD) in Germany (2016-2027) *
Table 10: Diagnosed Cases of the Atopic Dermatitis (AD) in Germany (2016-2027)
Table 11: Prevalent/Incident Cases of the Atopic Dermatitis (AD) in France (2016-2027)
Table 12: Sub-Type Specific cases of the Atopic Dermatitis (AD) in France (2016-2027) *
Table 13: Sex- Specific Cases of the Atopic Dermatitis (AD) in France (2016-2027) *
Table 14: Diagnosed Cases of the Atopic Dermatitis (AD) in France (2016-2027)
Table 15: Prevalent/Incident Cases of the Atopic Dermatitis (AD) in Italy (2016-2027)
Table 16: Sub-Type Specific cases of the Atopic Dermatitis (AD) in Italy (2016-2027) *
Table 17: Sex- Specific Cases of the Atopic Dermatitis (AD) in Italy (2016-2027) *
Table 18: Diagnosed Cases of the Atopic Dermatitis (AD) in Italy (2016-2027)
Table 19: Prevalent/Incident Cases of the Atopic Dermatitis (AD) in Spain (2016-2027)
Table 20: Sub-Type Specific cases of the Atopic Dermatitis (AD) in Spain (2016-2027) *
Table 21: Sex- Specific Cases of the Atopic Dermatitis (AD) in Spain (2016-2027) *
Table 22: Diagnosed Cases of the Atopic Dermatitis (AD) in Spain (2016-2027)
Table 23: Prevalent/Incident Cases of the Atopic Dermatitis (AD) in UK (2016-2027)
Table 24: Sub-Type Specific cases of the Atopic Dermatitis (AD) in UK (2016-2027) *
Table 25: Sex- Specific Cases of the Atopic Dermatitis (AD) in UK (2016-2027) *
Table 26: Diagnosed Cases of the Atopic Dermatitis (AD) in UK (2016-2027)
Table 27: Prevalent/Incident Cases of the Atopic Dermatitis (AD) in Japan (2016-2027)
Table 28: Sub-Type Specific cases of the Atopic Dermatitis (AD) in Japan (2016-2027) *
Table 29: Sex- Specific Cases of the Atopic Dermatitis (AD) in Japan (2016-2027) *
Table 30: Diagnosed Cases of the Atopic Dermatitis (AD) in Japan (2016-2027)

Get Free Sample

You can get a FREE sample of any report. Just click the "Free Sample" link.

Explore Latest Reports

If you have any special requirement or looking for more discounts, Kindly contact our sales team

Contact Us